| |
| |
|
| Insider
Information: |
Monia Brett P |
| Relationship: |
Director |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
180,289 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,548,038 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
180,289 |
|
|
| Total
Value |
$6,548,038 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -146.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
CEO Level 15, Director |
2024-02-29 |
174,289 |
2012-01-01 |
0 |
Premium* |
|
|
Cognition Therapeutics Inc |
CGTX |
Director |
2023-06-09 |
6,000 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
116 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2017-01-03 |
4 |
AS |
$48.60 |
$15,017 |
D/D |
(309) |
7,872 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2017-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,402 |
12,395 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2017-01-17 |
4 |
S |
$46.29 |
$115,819 |
D/D |
(2,502) |
11,772 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2017-07-01 |
4 |
A |
$40.66 |
$6,627 |
D/D |
163 |
11,935 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2017-07-03 |
4 |
AS |
$51.35 |
$15,867 |
D/D |
(309) |
11,626 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2018-01-01 |
4 |
A |
$42.76 |
$6,670 |
D/D |
156 |
11,782 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2018-01-02 |
4 |
AS |
$50.00 |
$8,150 |
D/D |
(163) |
11,619 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO |
• – – |
2018-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,985 |
18,604 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO |
• – – |
2018-01-16 |
4 |
S |
$51.76 |
$146,015 |
D/D |
(2,821) |
15,783 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-07-01 |
4 |
A |
$35.42 |
$7,580 |
D/D |
214 |
15,997 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-07-24 |
4 |
AS |
$47.03 |
$7,337 |
D/D |
(156) |
15,841 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-08-27 |
4 |
AS |
$54.00 |
$890,622 |
D/D |
(16,493) |
15,841 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-08-27 |
4 |
OE |
$7.21 |
$119,274 |
D/D |
16,493 |
23,341 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-11-23 |
4 |
AS |
$55.00 |
$1,870,058 |
D/D |
(34,000) |
15,841 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2018-11-23 |
4 |
OE |
$14.69 |
$499,460 |
D/D |
34,000 |
49,841 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2019-01-01 |
4 |
A |
$36.45 |
$7,654 |
D/D |
210 |
16,051 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2019-01-02 |
4 |
AS |
$53.50 |
$11,449 |
D/D |
(214) |
15,837 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2019-01-15 |
4 |
D |
$58.26 |
$208,105 |
D/D |
(3,572) |
22,275 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2019-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,006 |
25,847 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• • – |
2019-07-01 |
4 |
A |
$45.70 |
$7,907 |
D/D |
173 |
22,444 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• • – |
2019-07-02 |
4 |
AS |
$66.40 |
$13,944 |
D/D |
(210) |
22,234 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO & SVP, Translational Med |
• • – |
2019-11-20 |
4 |
AS |
$60.01 |
$346,618 |
D/D |
(5,776) |
16,458 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-01-02 |
4 |
AS |
$60.25 |
$10,423 |
D/D |
(173) |
16,285 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-01-15 |
4 |
D |
$62.06 |
$469,360 |
D/D |
(7,563) |
28,643 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,921 |
36,206 |
0 |
- |
|
116 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
